Docetaxel+Oxali+/-Cetux Met Gastric/GEJ
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Donald A Richards, MD
US Oncology Research
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
47 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Birmingham Hematology and Oncology
Birmingham, Alabama, United States
- Hematology Oncology Associates
Phoenix, Arizona, United States
- Rocky Mountain Cancer Center - Midtown
Denver, Colorado, United States
- Florida Cancer Institute
New Port Richey, Florida, United States
- Ocala Oncology Center
Ocala, Florida, United States
- Hematology Oncology Associates of Illinois
Chicago, Illinois, United States
- Cancer Care & Hematology Specialists of Chicagoland
Niles, Illinois, United States
- Central Indiana Cancer Centers
Indianapolis, Indiana, United States
- Hope Center
Terre Haute, Indiana, United States
- Kansas City Cancer Centers - Southwest
Overland Park, Kansas, United States
- Minnesota Oncology Hematology, P.A.
Minneapolis, Minnesota, United States
- Missouri Cancer Associates
Columbia, Missouri, United States
- New York Oncology Hematology, P.C.
Hudson, New York, United States
- Interlakes Oncology Hematology, Pc
Rochester, New York, United States
- Cancer Centers of North Carolina
Raleigh, North Carolina, United States
- Mahoning Valley Hematology Oncology Associates
Boardman, Ohio, United States
- Greater Dayton Cancer Center
Kettering, Ohio, United States
- Medical Oncology Associates
Kingston, Pennsylvania, United States
- Texas Oncology, P.A. Amarillo
Amarillo, Texas, United States
- Texas Cancer Center
Arlington, Texas, United States
- Texas Oncology Cancer Center
Austin, Texas, United States
- Mamie Mcfaddin Ward Cancer Center
Beaumont, Texas, United States
- Texas Oncology, P.A. - Bedford
Bedford, Texas, United States
- Methodist Charlton Cancer Ctr.
Dallas, Texas, United States
- Texas Cancer Center at Medical City
Dallas, Texas, United States
- Texas Oncology, P.A.
Dallas, Texas, United States
- Texas Oncology, P.A.
Dallas, Texas, United States
- Texas Cancer Center
Denton, Texas, United States
- El Paso Cancer Treatment Ctr
El Paso, Texas, United States
- Texas Oncology, P.A.
Fort Worth, Texas, United States
- Texas Oncology, P.A.
Garland, Texas, United States
- Lake Vista Cancer Center
Lewisville, Texas, United States
- Longview Cancer Center
Longview, Texas, United States
- Texas Cancer Center of Mesquite
Mesquite, Texas, United States
- Allison Cancer Center
Midland, Texas, United States
- Texas Oncology - Odessa
Odessa, Texas, United States
- Paris Regional Cancer Center
Paris, Texas, United States
- Tyler Cancer Center
Tyler, Texas, United States
- Texas Oncology Cancer and Research
Waco, Texas, United States
- Fairfax Northern Va Hem-Onc Pc
Arlington, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2007
- Primary completion
- 30 Apr 2012
- Completion
- 30 Apr 2012
- Last update posted
- 28 Nov 2016
- Registered enrollment
- 150
- Registry id
- NCT00517829
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.